tm logo

Monitor this mark

View On USPTO

IMLYGIC
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 04 Feb 2022

Last Applicant/ Owned by

Amgen Inc.

One Amgen Center Drive

Thousand Oaks

CA

913201799

Serial Number

85692936 filed on 01st Aug 2012

Registration Number

4889808 registered on 19th Jan 2016

in the Principal Register

Correspondent Address

Elsa D. Lemoine

Elsa D. Lemoine

Trademark Operations MS 28-5-A

One Amgen Center Drive

Thousand Oaks CA 91320-1799

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

IMLYGIC

Pharmaceutical preparations for use in the treatment of oncological diseases and disorders, and complications associated therewith

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for use in the treatment of oncological diseases and disorders, and complications associated therewith

First Use Date in General

03rd Nov 2015

First Use Date in Commerce

03rd Nov 2015

Mark Details

Serial Number

No 85692936

Mark Type

No Service/Collective Mark

Attorney Docket Number

No TM-1114-US-1

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
29th Apr 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
29th Apr 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
29th Apr 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
29th Apr 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
29th Apr 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
29th Apr 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
04th Feb 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
04th Feb 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04th Feb 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
19th Oct 2021TEAS SECTION 8 & 15 RECEIVED